SCI Abstract

search
+
The Impact of Family History on Clinical Presentation and Biologic Treatment Response in Patients with Psoriasis: A Multicenter Prospective Cohort Study
The Impact of Family History on Clinical Presentation and Biologic Treatment Response in Patients with Psoriasis: A Multicenter Prospective Cohort Study
Family history (FH) of psoriasis has been implicated as a risk factor for developing psoriasis. However, whether FH also c...
Individualized Neoantigen-Directed Melanoma Therapy
Individualized Neoantigen-Directed Melanoma Therapy
Individualized neoantigen-directed therapy represents a groundbreaking approach in melanoma treatment that leverages the p...
Morbilliform Eruptions: Differentiating Low-Risk Drug Eruptions, Severe Cutaneous Adverse Reactions, Viral Eruptions, and Acute Graft-Versus-Host Disease
Morbilliform Eruptions: Differentiating Low-Risk Drug Eruptions, Severe Cutaneous Adverse Reactions, Viral Eruptions, and Acute Graft-Versus-Host Disease
Morbilliform eruptions, which are a clinical reaction pattern characterized by erythematous macules and papules coalescing...
Safety of Hydroxychloroquine: What a Dermatologist Should Know
Safety of Hydroxychloroquine: What a Dermatologist Should Know
The unique immunomodulatory properties of hydroxychloroquine (HCQ) have attracted considerable interest beyond its use for...
Upadacitinib Dose Reduction Regimen in Elderly Patients with Atopic Dermatitis, Guided by Treat-to-Target Consensus Recommendations
Upadacitinib Dose Reduction Regimen in Elderly Patients with Atopic Dermatitis, Guided by Treat-to-Target Consensus Recommendations
The effectiveness of Janus kinase (JAK) inhibitors in treating atopic dermatitis (AD) is well established. However, little...
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study
Atopic dermatitis (AD) is a chronic inflammatory skin condition that significantly impairs the quality of life. Recent adv...
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis
Tralokinumab, a first-in-class and second biologic approved for treating moderate-to-severe atopic dermatitis in adolescen...
Clinical Outcomes and Prognostic Factors in Bullous Pemphigoid Patients: A 15-Year Review in China
Clinical Outcomes and Prognostic Factors in Bullous Pemphigoid Patients: A 15-Year Review in China
There are limited data on clinical outcomes and prognosis factors for bullous pemphigoid (BP) at long-term follow-up. We a...
Photoaging: Current Concepts on Molecular Mechanisms, Prevention, and Treatment
Photoaging: Current Concepts on Molecular Mechanisms, Prevention, and Treatment
Photoaging is the consequence of chronic exposure to solar irradiation, encompassing ultraviolet (UV), visible, and infrar...
Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years
Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years
There is a need for long-term atopic dermatitis (AD) treatments that can effectively improve AD involvement of the head an...
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution
Nail psoriasis (NP) affects up to 90% and 86% of patients with cutaneous psoriasis and psoriatic arthritis, respectively, ...
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis
Tapinarof cream 1% is an aryl hydrocarbon receptor agonist approved by the US Food and Drug Administration to treat atopic...
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching
Vulvovaginal itching is a common yet often under-recognized condition affecting women across all age groups. Despite its p...
Treat-to-Target in Atopic Dermatitis
Treat-to-Target in Atopic Dermatitis
Atopic dermatitis is one of the most common inflammatory skin diseases among children and adults. Over the last 5 years, t...
Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study
Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International ...
Review of Teledermatology: Lessons Learned from the COVID-19 Pandemic
Review of Teledermatology: Lessons Learned from the COVID-19 Pandemic
Utilization of telemedicine for dermatology has greatly expanded since the start of the COVID-19 pandemic, with over 500 n...
Photodynamic Therapy in Treating a Subset of Basal Cell Carcinoma: Strengths, Shortcomings, Comparisons with Surgical Modalities, and Potential Role as Adjunctive Therapy
Photodynamic Therapy in Treating a Subset of Basal Cell Carcinoma: Strengths, Shortcomings, Comparisons with Surgical Modalities, and Potential Role as Adjunctive Therapy
Basal cell carcinoma (BCC) is the most common skin cancer, for which there are multiple treatment options, including the g...
Correction to: Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Correction to: Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International ...
What’s New in Cutaneous T-Cell Lymphoma-Associated Pruritus
What’s New in Cutaneous T-Cell Lymphoma-Associated Pruritus
Cutaneous T-cell lymphomas are a heterogenous group of lymphomas that cause various skin manifestations. Severe pruritus o...
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives
Hormonal and immunologic changes during pregnancy can contribute to the development of different dermatoses, the most comm...
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
Dermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, ItalyLuca Stingeni, Rossella Mari...
Non-invasive Skin Imaging in Cutaneous Lymphomas
Non-invasive Skin Imaging in Cutaneous Lymphomas
The diagnosis of cutaneous lymphomas is challenging and requires skin tissue for histology and immunophenotyping using imm...
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Department of Pharmacy, Chang Gung Memorial Hospital, Linkou, Taoyuan, TaiwanChia-Ling Yu & Li-Huei ChiangDepartment o...
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1
Investigator’s Global Assessment of clear/almost clear skin (IGA 0/1) is a difficult endpoint to achieve after short...
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial
Treatment of moderate-to-severe plaque psoriasis with biologics, such as guselkumab, has demonstrated greater efficacy ove...
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments
Chronic prurigo (CPG) is a neuroinflammatory, fibrotic dermatosis that is defined by the presence of chronic pruritus (itc...
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
AtopyReg® is a multicenter, prospective, observational, non-profit cohort study on moderate-to-severe atopic dermatit...
Oral Lichen Planus: An Update on Diagnosis and Management
Oral Lichen Planus: An Update on Diagnosis and Management
Oral lichen planus (OLP) is a chronic inflammatory disease whose pathogenesis involves a T-cell mediated, epithelium-direc...
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Atopic dermatitis (AD) is a chronic inflammatory disease requiring efficacious and safe long-term therapy. Several new sys...
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Infammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Infammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Department of Pharmacy, Chang Gung Memorial Hospital, Linkou, Taoyuan, TaiwanChia-Ling Yu & Li-Huei ChiangDepartment o...
Load More
format_indent_increase